Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 71335-9713

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 71335-9713). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (B201c94c 128a 4ae1 86a1 057c4c895839 01)

Chemical structure diagram of esomeprazole magnesium, showing the molecular components including two aromatic rings and the magnesium ion complexed with water molecules.*

FDA Label Image

Figure 2: Maintenance Of Healing Rates By Month (study 177) (B201c94c 128a 4ae1 86a1 057c4c895839 02)

A line graph depicting the percentage maintained over a 6-month period for four groups: Esomeprazole Magnesium Delayed-Release Capsules 40 mg (with three sample sizes 92, 98, 91) and a placebo group (n=94). The graph shows a decline over time, with the placebo group dropping more sharply compared to the esomeprazole groups.*

FDA Label Image

Figure 3: Maintenance Of Healing Rates By Month (study 178) (B201c94c 128a 4ae1 86a1 057c4c895839 03)

A line graph displaying percent maintained over a six-month period for esomeprazole magnesium delayed-release capsules at strengths of 10 mg, 20 mg, and 40 mg, compared to placebo. The x-axis represents the months from 1 to 6, and the y-axis shows the percent maintained from 0 to 100%. Each strength and the placebo are represented by distinct dashed or solid lines.*

FDA Label Image

Figure 4: Percent Of Patients Symptom-free Of Heartburn By Day (study 225) Figure (B201c94c 128a 4ae1 86a1 057c4c895839 04)

A line graph showing the percent of patients symptom-free over a 28-day diary period. The graph compares esomeprazole magnesium delayed-release capsules at 40 mg and 20 mg doses against a placebo, with three distinct lines representing each group.*

FDA Label Image

Image (B201c94c 128a 4ae1 86a1 057c4c895839 05)

A line graph comparing the percent of patients symptom-free over 28 diary days among three groups: esomeprazole magnesium delayed-release capsules 40 mg, 20 mg, and placebo. The vertical axis shows percent symptom-free, and the horizontal axis represents diary days from 0 to 28.*

FDA Label Image

Label (Lbl713359713)

Label for esomeprazole magnesium delayed-release capsules USP 20 mg, repackaged by Bryant Ranch Prepack, Inc. and manufactured by Graviti Pharmaceuticals Pvt. Ltd. The container holds 30 capsules. Storage instructions and a QR code are present along with NDC 71335-9713-1 and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.